Observational Study of THC Concentrations in Acute Cannabis-induced CNS Depression

Part of paid clinical trials in Worcester, Massachusetts.

Sponsor
Anebulo Pharmaceuticals
Study ID
NCT06017622
Status
Recruiting
Apply to this trial

Conditions

  • Acute Cannabis-induced CNS Depression

Eligibility Criteria

Sex
ALL
Age
N/A - N/A
Healthy Volunteers
Not accepted

Study Details

This observational study is being conducted to determine plasma concentrations of tetrahydrocannabinol (THC) and its metabolites, 11-OH-THC and THC-COOH, in plasma of pediatric patients who visit the emergency department due to acute cannabis-induced CNS depression.

Key Dates

Start date
Jun 1, 2023
Status verified
Feb 2026
Primary completion
Dec 30, 2026
Completion
Dec 30, 2026

Study Design

Enrollment
36 participants (estimated)

Arms

  • Arm: All subjects
    There is a single group consisting of all subjects who meet the eligibility criteria

Primary Outcome Measure

Plasma Concentration of delta-9 tetrahydrocannabinol (THC) [ Time Frame: Day 1 ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
University of Massachusetts Memorial Children's Medical CenterWorcesterMassachusetts01605
Zachary W. Binder, MD
[email protected]
508-334-6090

Find similar trials in Worcester, MA

By research site
University of Massachusetts Memorial Children's Medical Center· Worcester, MA